These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27074557)

  • 1. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
    Cheng YC; Hueng DY; Huang HY; Chen JY; Chen Y
    Oncotarget; 2016 May; 7(20):29116-30. PubMed ID: 27074557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Evaluation of Honokiol and Magnolol on Apoptosis and Migration Inhibition in Human Bladder Cancer Cells.
    Wang HH; Chen Y; Changchien CY; Chang HH; Lu PJ; Mariadas H; Cheng YC; Wu ST
    Front Pharmacol; 2020; 11():549338. PubMed ID: 33240083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.
    Zhang P; Sun S; Li N; Ho ASW; Kiang KMY; Zhang X; Cheng YS; Poon MW; Lee D; Pu JKS; Leung GKK
    J Neurooncol; 2017 May; 132(3):393-400. PubMed ID: 28293765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
    BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
    Chakrabarti M; Ray SK
    Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
    Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
    Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo.
    Chen LC; Lee WS
    J Agric Food Chem; 2013 Mar; 61(11):2811-9. PubMed ID: 23448150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnolol Inhibits Human Glioblastoma Cell Migration by Regulating N-Cadherin.
    Cheng YC; Tsao MJ; Chiu CY; Kan PC; Chen Y
    J Neuropathol Exp Neurol; 2018 Jun; 77(6):426-436. PubMed ID: 29788114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
    Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.
    Kratzsch T; Kuhn SA; Joedicke A; Hanisch UK; Vajkoczy P; Hoffmann J; Fichtner I
    J Cancer Res Clin Oncol; 2018 May; 144(5):809-819. PubMed ID: 29427211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis.
    Lin CJ; Chang YA; Lin YL; Liu SH; Chang CK; Chen RM
    Phytomedicine; 2016 May; 23(5):517-27. PubMed ID: 27064011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
    Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma.
    Liu X; Sun K; Wang H; Dai Y
    Cell Mol Neurobiol; 2016 Oct; 36(7):1197-208. PubMed ID: 26971793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
    Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
    Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis by magnolol via the mitochondrial pathway and cell cycle arrest in renal carcinoma cells.
    Wen H; Zhou S; Song J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1271-1278. PubMed ID: 30573364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.
    Lv X; Liu F; Shang Y; Chen SZ
    Oncol Rep; 2015 Sep; 34(3):1289-300. PubMed ID: 26136140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
    Zhao M; Zheng YH; Zhao QY; Zheng W; Yang JH; Pei HY; Liu L; Liu KJ; Xue LL; Deng DX; Wang L; Ma X; Fu SH; Peng AH; Tang MH; Luo YZ; Ye HY; Chen LJ
    Eur J Med Chem; 2021 Jan; 209():112922. PubMed ID: 33069436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.